Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Jarrard

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
The Prostate|September 4, 2013
Epigenetic susceptibility factors for prostate cancer with agingN A Damaschke, B Yang, S Bhusari, et al.
Oncogene|January 10, 2002
Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cellsS R Schwarze, Y Shi, V X Fu, et al.
British Journal of Cancer|May 19, 2012
Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrenceM Truong, B Yang, J Wagner, et al.
The Prostate|January 1, 1994
Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasionD F Jarrard, B F Blitz, R C Smith, et al.
World Journal of Urology|September 16, 2016
A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancerM L Blute, J M Shiau, M Truong, et al.
Cancer Research|July 26, 2000
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancerH Kinoshita, Y Shi, C Sandefur, et al.
Cancer Research|December 16, 1998
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsD F Jarrard, H Kinoshita, Y Shi, et al.
Urologic Oncology|February 5, 2017
Multi-quadrant biopsy technique improves diagnostic ability in large heterogeneous renal masses. Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.J Urol. 2015 Oct;194(4):886-91. [Epub 2015 Mar 30]. doi: 10.1016/j.juro.2015.03.106Raman Jay, J E Heckman, L Hinshaw, et al.
Cancer Research|January 1, 1997
Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancerJ B Nelson, W H Lee, S H Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancerD F Jarrard, R Paul, A van Bokhoven, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
The Prostate|September 4, 2013
Epigenetic susceptibility factors for prostate cancer with agingN A Damaschke, B Yang, S Bhusari, et al.
Oncogene|January 10, 2002
Role of cyclin-dependent kinase inhibitors in the growth arrest at senescence in human prostate epithelial and uroepithelial cellsS R Schwarze, Y Shi, V X Fu, et al.
British Journal of Cancer|May 19, 2012
Even-skipped homeobox 1 is frequently hypermethylated in prostate cancer and predicts PSA recurrenceM Truong, B Yang, J Wagner, et al.
The Prostate|January 1, 1994
Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasionD F Jarrard, B F Blitz, R C Smith, et al.
World Journal of Urology|September 16, 2016
A biopsy-integrated algorithm for determining Gleason 6 upgrading risk stratifies risk of active surveillance failure in prostate cancerM L Blute, J M Shiau, M Truong, et al.
Cancer Research|July 26, 2000
Methylation of the androgen receptor minimal promoter silences transcription in human prostate cancerH Kinoshita, Y Shi, C Sandefur, et al.
Cancer Research|December 16, 1998
Methylation of the androgen receptor promoter CpG island is associated with loss of androgen receptor expression in prostate cancer cellsD F Jarrard, H Kinoshita, Y Shi, et al.
Urologic Oncology|February 5, 2017
Multi-quadrant biopsy technique improves diagnostic ability in large heterogeneous renal masses. Abel EJ, Heckman JE, Hinshaw L, Best S, Lubner M, Jarrard DF, Downs TM, Nakada SY, Lee FT Jr, Huang W, Ziemlewicz T.J Urol. 2015 Oct;194(4):886-91. [Epub 2015 Mar 30]. doi: 10.1016/j.juro.2015.03.106Raman Jay, J E Heckman, L Hinshaw, et al.
Cancer Research|January 1, 1997
Methylation of the 5' CpG island of the endothelin B receptor gene is common in human prostate cancerJ B Nelson, W H Lee, S H Nguyen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 17, 1998
P-Cadherin is a basal cell-specific epithelial marker that is not expressed in prostate cancerD F Jarrard, R Paul, A van Bokhoven, et al.
Pageof 3